Description

Sandimmun Neoral (cyclosporin) Soft Capsules 50 mg. №50

The recommended dosage of Sandimmun Neoral soft capsules is determined by a healthcare provider based on individual factors.

Sandimmun Neoral is indicated for the prevention of organ rejection in kidney, liver, and heart transplant patients.

Do not use Sandimmun Neoral if you are allergic to cyclosporin or any other ingredients in the product.

Take Sandimmun Neoral exactly as prescribed by your healthcare provider. Do not crush or chew the capsules.

Sandimmun Neoral (cyclosporin) has been extensively studied in clinical trials for its efficacy in preventing organ rejection. The drug works by suppressing the immune system to reduce the risk of transplant rejection. Research has shown that cyclosporin is a cornerstone in transplant medicine due to its effectiveness and tolerability.
In a study published in the Journal of the American Society of Nephrology, cyclosporin was found to significantly improve graft survival rates in kidney transplant recipients compared to other immunosuppressive agents. The study highlighted the importance of cyclosporin in long-term transplant outcomes.

It is important to follow your healthcare provider’s instructions carefully while taking Sandimmun Neoral to achieve the best results and minimize the risk of side effects.
Discuss any concerns or questions about Sandimmun Neoral with your healthcare provider to ensure safe and effective treatment.